FGF23 and uremia: In a previous investigation, we administered the FGF receptor inhibitor, PD173074, to uremic normocalcemic rats and found a large increase in plasma PTH indicating that the suppressive tonus of FGF23 on the parathyroid gland is still present in uremia, when plasma Ca2+ is within normal range [26].